Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -3.56% vs 13.66% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 16.57% vs 49.88% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 6.05% vs 54.30% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -80.00% vs 185.71% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Jiangsu Hengrui Pharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -3.56% vs 13.66% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 12.98% vs 20.14% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 16.57% vs 49.88% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 21.56% vs 37.21% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 6.05% vs 54.30% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 12.05% vs 36.19% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -80.00% vs 185.71% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -96.33% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






